Statistics
Publications
25
Citations
3.4K
H-Index
19
Active since
2006
Gerson Peltz is an author at Pfizer (United States) specializing in medicine, oncology, and pharmacology.
Publications per year
2006–2023
25
25
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer
Alice T. Shaw, Todd M. Bauer, Filippo de Marinis et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +16
The role of fat mass index in determining obesity
Gerson Peltz, María Teresa Holguín Aguirre, Maureen Sanderson et al. · American Journal of Human Biology · 2010 · 194 citations
Clinical Management of Adverse Events Associated with Lorlatinib
Todd M. Bauer, Enriqueta Felip, Benjamin Solomon et al. · The Oncologist · 2019 · 162 citations · Full text
1–5 of 25